In this context, the aim of the present study was to define the role of Delta-like ligand stimulation in NOTCH1-mutated CLL cells as well as to explore the therapeutic disruption of this signaling with a specific anti-NOTCH1 antibody. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.